SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000902664-19-004399
Filing Date
2019-11-20
Accepted
2019-11-20 21:53:22
Documents
1
Period of Report
2019-11-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 7590
  Complete submission text file 0000902664-19-004399.txt   9104
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 1345 AVENUE OF THE AMERICAS, 15TH FLOOR NEW YORK NY 10105
Business Address
Dai Chengxiang (Reporting) CIK: 0001794289 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36498 | Film No.: 191235584